by Barry Jaruzelski, John Loehr, and Richard Holman
The early stages of innovation can be challenging. But Booz & Company’s annual study of R&D spending reveals that successful innovators bring clarity to a process often described as fuzzy and vague.
In this issue
A Strategist’s Guide to Personalized Medicine, Overcoming the Global Innovation Trade-Off, The Thought Leader Interview: William J. O’Rourke, and More
Breakthroughs in pharmaceutical innovation are poised to change the prevailing business model of the industry — with dramatic effects on healthcare costs and practice.
These fundamental guidelines, drawn from experience, can help you reshape your organization to fit your business strategy. See also “A guide to organization design.”
Low-income markets present a prodigious opportunity for the world’s wealthiest companies — to seek their fortunes and bring prosperity to the aspiring poor.